PipelinePharma Logo

dimenhydrinate Tablets 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Palestinian Territory
GMP approvals
Jordan
Manufacturer #20728

This CTD dossier owner and manufacturer, established in 1969, focuses on developing and manufacturing a wide range of high-quality pharmaceutical products. Their portfolio encompasses prescription medications, over-the-counter drugs, sterile liquids, semi-solids, solids (including capsules, tablets, powders), and liquids like oral drops, syrups, solutions, suspensions, and sprays. They hold certifications from key regulatory bodies in regions like the EU and North America, demonstrating their commitment to quality and safety. The company specializes in several therapy areas, including but not limited to [list specific therapy areas if mentioned in the information]. Their production lines utilize GMP practices and leverage product patents to ensure efficacy and innovation.

Dimenhydrinate is a pharmaceutical drug that is used to treat insomnia, vertigo and nausea. As a standalone drug, it is primarily marketed as dimenhydrinate tablets but is also available in liquid and suppository form. Depending on the formulation, it is can be administered orally, or by way of either intravenous or intramuscular injection. Dimenhydrinate is also commonly used as an ingredient in combination drugs, along with substances such as cinnarizine, pyridoxine, paracetamol, and others. Major suppliers of trade name dimenhydrinate medications include Pfizer, Sandoz, and Teva. On the other hand, suppliers Fresenius Kabi, Mylan are few of the distributors of generic versions of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.